Genmab A/S (United States) is listed on the Nasdaq and has a market capitalization of $17.59 Billions, with shareholders equity totaling $5.85 Billions.
The company employs approximately 781 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Genmab A/S reported $3.11 Billions in revenue, generating net income of $796.26 Millions.
Key financial metrics include a P/E ratio of 22.09, a price-to-book (P/B) ratio of 3.01, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker GMAB.